Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Mutation Analysis of Gap Junction Protein Beta 1 and Genotype-Phenotype Correlation in X-linked Charcot-Marie-Tooth Disease in Chinese Patients.
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.
Secondary Progressive Multiple Sclerosis: Definition and Measurement.
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.
Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM.
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
Rapid, sustained and reversible pharmacodynamics of DAC HYP in MS patients supports mechanism of action via modulation of the IL-2 pathway
Episode 25 with actor and science advocate Alan Alda discussing communicating science
Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
Eosinophilic Fasciitis-like Disorder Developing in the Setting of Multiple Sclerosis Therapy.
UCSF Seminar: "MRI of Lesion Development and Repair in Multiple Sclerosis"
CombiRx for MS not better than monotherapy
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis.
Episode 11 with Dr. Jack Antel on remyelination and on bedside-to-bench research
Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
Interferon beta 1a anaphylaxis, a case report. Standardization of non-irritating concentration for allergy skin.
Dimethylfumarate induces apoptosis in human mast cells.
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging.
Neuroimmunomodulation by allogeneic seminal vesicle fluid in CNS is sex-independent.
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Microglia across the lifespan: from origin to function in brain development, plasticity and cognition.
Social Media Representation of Chronic Cerebrospinal Venous Insufficiency Intervention for Multiple Sclerosis.
A case of posterior reversible encephalopathy syndrome associated with gilenya(®) (fingolimod) treatment for multiple sclerosis.
12-oxo-phytodienoic acid, a plant-derived oxylipin, attenuates lipopolysaccharide-induced inflammation in microglia.
Interferon-beta-1b protects against multiple sclerosis-induced endothelial cells apoptosis.

Pages